Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature
1Department of Oncology, Xuzhou Central Hospital Affiliated to Dongnan University, Xuzhou, Jiangsu, China.
Rationale:
Peripheral primitive neuroectodermal tumor (PNET) is a kind of small round cell tumor derived from primitive neuroectodermal tumor.
Patient Concerns:
PNET is a highly malignant tumor that is subordinated to Ewing sarcoma. It occurs predominantly in soft tissue and bone and rarely in the bronchi and lung. Traditional surgery, radiotherapy, and chemotherapy are used for the treatment of PNET, but are usually ineffective.
Diagnoses:
There was a rare case of a 17 year-old man diagnoses with primary pulmonary PNET.
Interventions:
The patient was treated by the remedy treatment with thalidomide after the poor effect of conventional radiotherapy and chemotherapy.
Outcomes:
The patient survived without disease progression for 15 months and was in stable condition.
Lessons:
Thalidomide provides a choice for maintenance therapy in PNET.
Related Concept Videos
01:10Review and Preview
Percentiles are a type of fractile that partition data into...
01:13Review and Preview
01:24Data Reporting and Recording
00:59Gene Therapy
01:25Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
01:21Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...